{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:14Z","timestamp":1781835734610,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10909-1","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T13:54:00Z","timestamp":1755093240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential role of pentraxin 3 (PTX3) and aldehyde dehydrogenase (ALDH) in liver cirrhotic patients: predicting and diagnostic impact in hepatocellular carcinoma (HCC) development"],"prefix":"10.1007","volume":"52","author":[{"given":"Hoda M.","family":"El-Emshaty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsaid Ali","family":"Eladle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma M.","family":"Khirallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"10909_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/medsci13010013","volume":"13","author":"H Fadlallah","year":"2025","unstructured":"Fadlallah H, Masri DE, Bahmad HF, Abou-Kheir W, Masri JE (2025) Update on the complications and management of liver cirrhosis. Med Sci 13:1\u201329. https:\/\/doi.org\/10.3390\/medsci13010013","journal-title":"Med Sci"},{"key":"10909_CR2","doi-asserted-by":"publisher","unstructured":"Younossi Z, Papatheodoridis G, Cacoub P, Negro F, Wedemeyer H, Henry L, Hatzakis A (2018) The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease. J Viral Hepat 25 Suppl 36\u201314. https:\/\/doi.org\/10.1111\/jvh.13005","DOI":"10.1111\/jvh.13005"},{"key":"10909_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.21103\/article6(3)_oa7","volume":"6","author":"D Konstantinov","year":"2016","unstructured":"Konstantinov D, Popova L, Konstantinova E (2016) Hepatocellular carcinoma in patients with chronic hepatitis C. Int J Biomed 6:195\u2013198. https:\/\/doi.org\/10.21103\/article6(3)_oa7","journal-title":"Int J Biomed"},{"key":"10909_CR4","doi-asserted-by":"publisher","unstructured":"Vesterhus M, Nielsen MJ, Hov JR, Saffioti F, Manon-Jensen T, Leeming DJ, Moum B, Boberg KM, Pinzani M, Karlsen TH, Karsdal MA, Thorburn D (2021) Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease. JHEP Rep 3. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100178","DOI":"10.1016\/j.jhepr.2020.100178"},{"key":"10909_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/BTT.S23907","volume":"6","author":"CL Tinkle","year":"2012","unstructured":"Tinkle CL, Haas-Kogan D (2012) Hepatocellular carcinoma: natural history, current management, and emerging tools. Biologics 6:207\u2013219. https:\/\/doi.org\/10.2147\/BTT.S23907","journal-title":"Biologics"},{"key":"10909_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S1470-2045(12)70271-1","volume":"13","author":"A Forner","year":"2012","unstructured":"Forner A, Bruix J (2012) Biomarkers for early diagnosis of hepatocellular carcinoma. Lancet Oncol 13:750\u2013751. https:\/\/doi.org\/10.1016\/S1470-2045(12)70271-1","journal-title":"Lancet Oncol"},{"key":"10909_CR7","doi-asserted-by":"publisher","first-page":"13519","DOI":"10.1038\/s41598-020-70241-5","volume":"10","author":"G Wang","year":"2020","unstructured":"Wang G, Lu X, Du Q, Zhang G, Wang D, Wang Q, Guo X (2020) Diagnostic value of the \u03b3-glutamyltransferase and Alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma. Sci Rep 10:13519. https:\/\/doi.org\/10.1038\/s41598-020-70241-5","journal-title":"Sci Rep"},{"key":"10909_CR8","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.3748\/wjg.v18.i31.4071","volume":"18","author":"H Nakagawa","year":"2012","unstructured":"Nakagawa H, Maeda S (2012) Inflammation- and stress-related signaling pathways in hepatocarcinogenesis. World J Gastroenterol 18:4071\u20134081. https:\/\/doi.org\/10.3748\/wjg.v18.i31.4071","journal-title":"World J Gastroenterol"},{"key":"10909_CR9","doi-asserted-by":"publisher","unstructured":"Mititelu RR, P\u0103dureanu R, B\u0103c\u0103noiu M, P\u0103dureanu V, Docea AO, Calina D, Barbulescu AL, Buga AM (2020) Inflammatory and oxidative stress Markers-Mirror tools in rheumatoid arthritis. Biomedicines 8. https:\/\/doi.org\/10.3390\/biomedicines8050125","DOI":"10.3390\/biomedicines8050125"},{"key":"10909_CR10","doi-asserted-by":"publisher","unstructured":"Padureanu R, Albu CV, Mititelu RR, Bacanoiu MV, Docea AO, Calina D, Padureanu V, Olaru G, Sandu RE, Malin RD, Buga A-M (2019) Oxidative stress and inflammation interdependence in multiple sclerosis. J Clin Med 8. https:\/\/doi.org\/10.3390\/jcm8111815","DOI":"10.3390\/jcm8111815"},{"key":"10909_CR11","doi-asserted-by":"publisher","first-page":"2703518","DOI":"10.1155\/2018\/2703518","volume":"2018","author":"T Angkananard","year":"2018","unstructured":"Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A (2018) Neutrophil lymphocyte ratio and cardiovascular disease risk: A systematic review and Meta-Analysis. Biomed Res Int 2018:2703518. https:\/\/doi.org\/10.1155\/2018\/2703518","journal-title":"Biomed Res Int"},{"key":"10909_CR12","doi-asserted-by":"publisher","unstructured":"Liberski PS, Szewczyk M, Krzych \u0141J (2020) Haemogram-Derived indices for screening and prognostication in critically ill septic shock patients: A Case-Control study., diagnostics (Basel, Switzerland). 10. https:\/\/doi.org\/10.3390\/diagnostics10090638","DOI":"10.3390\/diagnostics10090638"},{"key":"10909_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1189\/jlb.1005557","volume":"79","author":"B Bottazzi","year":"2006","unstructured":"Bottazzi B, Bastone A, Doni A, Garlanda C, Valentino S, Deban L, Maina V, Cotena A, Moalli F, Vago L, Salustri A, Romani L, Mantovani A (2006) The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol 79:909\u2013912. https:\/\/doi.org\/10.1189\/jlb.1005557","journal-title":"J Leukoc Biol"},{"key":"10909_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi B, Doni A, Garlanda C, Mantovani A (2010) An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 28:157\u2013183. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101305","journal-title":"Annu Rev Immunol"},{"key":"10909_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev.immunol.23.021704.115756","volume":"23","author":"C Garlanda","year":"2005","unstructured":"Garlanda C, Bottazzi B, Bastone A, Mantovani A (2005) Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 23:337\u2013366. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115756","journal-title":"Annu Rev Immunol"},{"key":"10909_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3389\/fimmu.2019.00794","volume":"10","author":"R Porte","year":"2019","unstructured":"Porte R, Davoudian S, Asgari F, Parente R, Mantovani A, Garlanda C, Bottazzi B (2019) The long pentraxin PTX3 as a humoral innate immunity functional player and biomarker of infections and sepsis. Front Immunol 10:794. https:\/\/doi.org\/10.3389\/fimmu.2019.00794","journal-title":"Front Immunol"},{"key":"10909_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fimmu.2019.00823","volume":"10","author":"G Ristagno","year":"2019","unstructured":"Ristagno G, Fumagalli F, Bottazzi B, Mantovani A, Olivari D, Novelli D, Latini R (2019) Pentraxin 3 in cardiovascular disease. Front Immunol 10:823. https:\/\/doi.org\/10.3389\/fimmu.2019.00823","journal-title":"Front Immunol"},{"key":"10909_CR18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/hep.22010","volume":"46","author":"S Zakhari","year":"2007","unstructured":"Zakhari S, Li T-K (2007) Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 46:2032\u20132039. https:\/\/doi.org\/10.1002\/hep.22010","journal-title":"Hepatology"},{"key":"10909_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/modpathol.2013.189","volume":"27","author":"L Yang","year":"2014","unstructured":"Yang L, Ren Y, Yu X, Qian F, Bian B-S-J, Xiao H, Wang W, Xu S, Yang J, Cui W, Liu Q, Wang Z, Guo W, Xiong G, Yang K, Qian C, Zhang X, Zhang P, Cui Y, Bian X (2014) ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma. Mod Pathol Off J United States Can Acad Pathol Inc 27:775\u2013783. https:\/\/doi.org\/10.1038\/modpathol.2013.189","journal-title":"Mod Pathol Off J United States Can Acad Pathol Inc"},{"key":"10909_CR20","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/onc.2013.226","volume":"33","author":"Q Li","year":"2014","unstructured":"Li Q, Yao Y, Eades G, Liu Z, Zhang Y, Zhou Q (2014) Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer. Oncogene 33:2589\u20132600. https:\/\/doi.org\/10.1038\/onc.2013.226","journal-title":"Oncogene"},{"key":"10909_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.jhep.2010.12.043","volume":"55","author":"X Chen","year":"2011","unstructured":"Chen X, Lingala S, Khoobyari S, Nolta J, Zern MA, Wu J (2011) Epithelial mesenchymal transition and Hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. J Hepatol 55:838\u2013845. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.043","journal-title":"J Hepatol"},{"key":"10909_CR22","doi-asserted-by":"publisher","unstructured":"Kanki K, Watanabe R, Nguyen Thai L, Zhao C-H, Naito K (2020) HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth., Cancers (Basel). 12 https:\/\/doi.org\/10.3390\/cancers12102734","DOI":"10.3390\/cancers12102734"},{"key":"10909_CR23","doi-asserted-by":"publisher","unstructured":"Lv D, Chen L, Du L, Zhou L, Tang H (2021) Emerging regulatory mechanisms involved in liver cancer stem cell properties in hepatocellular carcinoma, front. Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/fcell.2021.691410","DOI":"10.3389\/fcell.2021.691410"},{"key":"10909_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.tips.2019.08.002","volume":"40","author":"SS Dinavahi","year":"2019","unstructured":"Dinavahi SS, Bazewicz CG, Gowda R, Robertson GP (2019) Aldehyde dehydrogenase inhibitors for cancer therapeutics. Trends Pharmacol Sci 40:774\u2013789. https:\/\/doi.org\/10.1016\/j.tips.2019.08.002","journal-title":"Trends Pharmacol Sci"},{"key":"10909_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/gut.50.6.881","volume":"50","author":"I Levy","year":"2002","unstructured":"Levy I, Sherman M (2002) Staging of hepatocellular carcinoma: assessment of the CLIP, okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50:881\u2013885. https:\/\/doi.org\/10.1136\/gut.50.6.881","journal-title":"Gut"},{"key":"10909_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.32604\/biocell.2018.07009","volume":"42","author":"HM El-Emshaty","year":"2018","unstructured":"El-Emshaty HM, Saad EA, Gouida MS, Elshahawy ZR (2018) Associations between CD133, CK19 and G2\/M in cirrhotic HCV (Genotype-4) patients with or without accompanying tumor. Biocell 42:55\u201360. https:\/\/doi.org\/10.32604\/biocell.2018.07009","journal-title":"Biocell"},{"key":"10909_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142:1264\u20131273.e1. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"10909_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","volume":"245","author":"J Ozer","year":"2008","unstructured":"Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194\u2013205. https:\/\/doi.org\/10.1016\/j.tox.2007.11.021","journal-title":"Toxicology"},{"key":"10909_CR29","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/2012.jama.11975","volume":"308","author":"C-Y Wu","year":"2012","unstructured":"Wu C-Y, Chen Y-J, Ho HJ, Hsu Y-C, Kuo KN, Wu M-S, Lin J-T (2012) Association between nucleoside analogues and risk of hepatitis B virus\u2013related hepatocellular carcinoma recurrence following liver resection. JAMA 308:1906\u20131914. https:\/\/doi.org\/10.1001\/2012.jama.11975","journal-title":"JAMA"},{"key":"10909_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet L-P, Brightling C, Chanez P, Dahlen S-E, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG (2014) International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43:343\u2013373. https:\/\/doi.org\/10.1183\/09031936.00202013","journal-title":"Eur Respir J"},{"key":"10909_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","volume":"44","author":"J Parkes","year":"2006","unstructured":"Parkes J, Guha IN, Roderick P, Rosenberg W (2006) Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 44:462\u2013474. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.019","journal-title":"J Hepatol"},{"key":"10909_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s1542-3565(05)00855-4","volume":"4","author":"H Toyoda","year":"2006","unstructured":"Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J (2006) Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 4:111\u2013117. https:\/\/doi.org\/10.1016\/s1542-3565(05)00855-4","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10909_CR33","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/s0959-8049(98)00056-2","volume":"34","author":"J Raedle","year":"1998","unstructured":"Raedle J, Oremek G, Truschnowitsch M, Lorenz M, Roth WK, Caspary WF, Zeuzem S (1998) Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma. Eur J Cancer 34:1198\u20131203. https:\/\/doi.org\/10.1016\/s0959-8049(98)00056-2","journal-title":"Eur J Cancer"},{"key":"10909_CR34","doi-asserted-by":"publisher","unstructured":"Chang Y, Liu B, Niu H, Wang Z, Xia S, Li H (2020) Value of anti-p53 antibody as a biomarker for hepatocellular carcinoma: evidence from a meta-analysis. Med (Baltim) 99. https:\/\/doi.org\/10.1097\/MD.0000000000021887","DOI":"10.1097\/MD.0000000000021887"},{"key":"10909_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/liv.15099","volume":"42","author":"PN Brennan","year":"2022","unstructured":"Brennan PN, Dillon JF, Tapper EB (2022) Gamma-Glutamyl transferase (\u03b3-GT) - an old dog with new tricks? Liver int. Off J Int Assoc Study Liver 42:9\u201315. https:\/\/doi.org\/10.1111\/liv.15099","journal-title":"Off J Int Assoc Study Liver"},{"key":"10909_CR36","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/hep.24123","volume":"53","author":"L Valenti","year":"2011","unstructured":"Valenti L, Rumi M, Galmozzi E, Aghemo A, Del Menico B, De Nicola S, Dongiovanni P, Maggioni M, Fracanzani AL, Rametta R, Colombo M, Fargion S (2011) Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C. Hepatology 53:791\u2013799. https:\/\/doi.org\/10.1002\/hep.24123","journal-title":"Hepatology"},{"key":"10909_CR37","first-page":"1459","volume":"56","author":"R Vardar","year":"2009","unstructured":"Vardar R, Vardar E, Demiri S, Sayhan SE, Bayol U, Yildiz C, Postaci H (2009) Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis? Hepatogastroenterology 56:1459\u20131465","journal-title":"Hepatogastroenterology"},{"key":"10909_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s0168-8278(01)00088-5","volume":"35","author":"X Forns","year":"2001","unstructured":"Forns X, Ampurdan\u00e8s S, Sanchez-Tapias JM, Guilera M, Sans M, S\u00e1nchez-Fueyo A, Quint\u00f3 L, Joya P, Bruguera M, Rod\u00e9s J (2001) Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 35:265\u2013271. https:\/\/doi.org\/10.1016\/s0168-8278(01)00088-5","journal-title":"J Hepatol"},{"key":"10909_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.coi.2008.05.004","volume":"20","author":"AA Manfredi","year":"2008","unstructured":"Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A (2008) Pentraxins, humoral innate immunity and tissue injury. Curr Opin Immunol 20:538\u2013544. https:\/\/doi.org\/10.1016\/j.coi.2008.05.004","journal-title":"Curr Opin Immunol"},{"key":"10909_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.semarthrit.2008.03.006","volume":"39","author":"O-D Ortega-Hernandez","year":"2009","unstructured":"Ortega-Hernandez O-D, Bassi N, Shoenfeld Y, Anaya J-M (2009) The long pentraxin 3 and its role in autoimmunity. Semin Arthritis Rheum 39:38\u201354. https:\/\/doi.org\/10.1016\/j.semarthrit.2008.03.006","journal-title":"Semin Arthritis Rheum"},{"key":"10909_CR41","doi-asserted-by":"publisher","first-page":"20276","DOI":"10.1038\/s41598-020-77332-3","volume":"10","author":"H Deng","year":"2020","unstructured":"Deng H, Fan X, Wang X, Zeng L, Zhang K, Zhang X, Li N, Han Q, Lv Y, Liu Z (2020) Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection. Sci Rep 10:20276. https:\/\/doi.org\/10.1038\/s41598-020-77332-3","journal-title":"Sci Rep"},{"key":"10909_CR42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10238-020-00617-4","volume":"20","author":"S Feder","year":"2020","unstructured":"Feder S, Haberl EM, Spirk M, Weiss TS, Wiest R, Buechler C (2020) Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients. Clin Exp Med 20:289\u2013297. https:\/\/doi.org\/10.1007\/s10238-020-00617-4","journal-title":"Clin Exp Med"},{"key":"10909_CR43","doi-asserted-by":"publisher","first-page":"780","DOI":"10.5604\/01.3001.0010.2789","volume":"16","author":"JG Pereira","year":"2017","unstructured":"Pereira JG, Silva TE, Bansho ETO, Morato EF, Pinheiro JT, Muraro-Wildner L, Bazzo ML, Dantas-Corr\u00eaa EB, Schiavon LL, Narciso-Schiavon JL (2017) Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis. Ann Hepatol 16:780\u2013787. https:\/\/doi.org\/10.5604\/01.3001.0010.2789","journal-title":"Ann Hepatol"},{"key":"10909_CR44","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jmii.2015.12.006","volume":"50","author":"W-C Fan","year":"2017","unstructured":"Fan W-C, Huang C-C, Yang Y-Y, Lin A, Lee K-C, Hsieh Y-C, Fung C-P, Hsu H-C, Hou M-C, Lin H-C (2017) Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients. J Microbiol Immunol Infect 50:905\u2013914. https:\/\/doi.org\/10.1016\/j.jmii.2015.12.006","journal-title":"J Microbiol Immunol Infect"},{"key":"10909_CR45","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00005-022-00667-4","volume":"71","author":"B Wolszczak-Biedrzycka","year":"2022","unstructured":"Wolszczak-Biedrzycka B, Bie\u0144kowska A, Zasimowicz E, Biedrzycki G, Dorf J, Jelski W (2022) An assessment of the serum activity of ADH and ALDH in patients with primary biliary cholangitis. Arch Immunol Ther Exp (Warsz) 71:2. https:\/\/doi.org\/10.1007\/s00005-022-00667-4","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10909_CR46","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1515\/CCLM.2000.059","volume":"38","author":"L Chrostek","year":"2000","unstructured":"Chrostek L, Szmitkowski M (2000) The activity of class I and II alcohol dehydrogenase isoenzymes in the Sera of patients with liver tumours. Clin Chem Lab Med 38:409\u2013412. https:\/\/doi.org\/10.1515\/CCLM.2000.059","journal-title":"Clin Chem Lab Med"},{"key":"10909_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.7754\/Clin.Lab.2017.170925","volume":"64","author":"W Jelski","year":"2018","unstructured":"Jelski W, Wolszczak-Biedrzycka B, Zasimowicz-Majewska E, Orywal K, Piechota J, Lapinski TW, Bednarczyk M, Szmitkowski M (2018) The activity of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in the Sera of patients with autoimmune hepatitis. Clin Lab 64:477\u2013481. https:\/\/doi.org\/10.7754\/Clin.Lab.2017.170925","journal-title":"Clin Lab"},{"key":"10909_CR48","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.21873\/anticanres.12688","volume":"38","author":"W Jelski","year":"2018","unstructured":"Jelski W, Wolszczak-Biedrzycka B, Zasimowicz-Majewska E, Orywal K, Lapinski TW, Szmitkowski M (2018) Alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the serum of patients with Non-alcoholic fatty liver disease. Anticancer Res 38:4005\u20134009. https:\/\/doi.org\/10.21873\/anticanres.12688","journal-title":"Anticancer Res"},{"key":"10909_CR49","doi-asserted-by":"publisher","first-page":"e22964","DOI":"10.1002\/jcla.22964","volume":"33","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y (2019) Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal 33:e22964. https:\/\/doi.org\/10.1002\/jcla.22964","journal-title":"J Clin Lab Anal"},{"key":"10909_CR50","unstructured":"Sarma KVS (2018) Some aspects of surrogate biomarkers using ROC curve analysis, 45\u201349"},{"key":"10909_CR51","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ajg.2011.100","volume":"106","author":"J Boursier","year":"2011","unstructured":"Boursier J, de Ledinghen V, Zarski J-P, Rousselet M-C, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, Oberti F, Dib N, Cal\u00e8s P (2011) A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C. Am J Gastroenterol 106:1255\u20131263. https:\/\/doi.org\/10.1038\/ajg.2011.100","journal-title":"Am J Gastroenterol"},{"key":"10909_CR52","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3748\/wjg.v22.i4.1367","volume":"22","author":"P Valva","year":"2016","unstructured":"Valva P, R\u00edos DA, De Matteo E, Preciado MV (2016) Chronic hepatitis C virus infection: serum biomarkers in predicting liver damage. World J Gastroenterol 22:1367\u20131381. https:\/\/doi.org\/10.3748\/wjg.v22.i4.1367","journal-title":"World J Gastroenterol"},{"key":"10909_CR53","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3748\/wjg.v20.i11.2854","volume":"20","author":"LdeL Schiavon","year":"2014","unstructured":"Schiavon LdeL, Narciso-Schiavon JL, de Carvalho-Filho RJ (2014) Non-invasive diagnosis of liver fibrosis in chronic hepatitis C. World J Gastroenterol 20:2854\u20132866. https:\/\/doi.org\/10.3748\/wjg.v20.i11.2854","journal-title":"World J Gastroenterol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10909-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:27:42Z","timestamp":1766896062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10909-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10909"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10909-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design was approved by the ethics committee of the Faculty of Science - Port Said University - Egypt (ERN: PSU. Sci. 4) in accordance with the ethical standards of the Helsini Declaration. Before the trial protocol started, each participant in this investigation gave written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"826"}}